BioSpace News Archive

Bio-Techne Corporation announced it will showcase its portfolio of cell and gene therapy workflow solutions at the upcoming annual meeting of the American Society of Gene & Cell Therapy, taking place May 7-11, 2024, in Baltimore, Maryland.

Mikart, LLC, a leading contract development and manufacturing organization, is thrilled to announce a significant milestone in its collaboration with Nano PharmaSolutions, Inc..

Nanoscope Therapeutics Inc. announced that its viral and laser-delivered Multi-Characteristic Opsin gene therapy platforms will be featured in multiple presentations at the 2024 ASGCT Annual Meeting and the Retina World Congress, being held in Baltimore, Maryland and Fort Lauderdale, Florida, respectively, in May.

Ionis Pharmaceuticals, Inc., reported financial results for the first quarter ended March 31, 2024.

Circular Genomics announced study results published as a preprint on bioRXiv demonstrating the potential for Circular Genomics’ first blood assay to predict patient response to sertraline as well as capacity for SSRI class prediction overall.

Fusion Pharmaceuticals Inc. reported financial results for the first quarter ended March 31, 2024, and provided an update on clinical and corporate developments.

Hopewell Therapeutics announced that the Company will present preclinical data demonstrating progression of its pulmonary, oncology and vaccine programs at the American Society of Gene and Cell Therapy 27th Annual Meeting being held this week in Baltimore, MD, as well as virtually.

Care Enablement delivered strong sequential margin improvement with significant progress towards the 2025 target margin band.

Anjarium Biosciences, a cell and gene therapy tools and technology company enabling researchers and manufacturers to accelerate the discovery and delivery cycle of new and evolving genetic medicines, announced presentation of five scientific posters at the American Society of Gene and Cell Therapy annual meeting in Baltimore, Maryland, May 7-11, 2024.

Novanta Inc., a trusted technology partner to medical and advanced technology equipment manufacturers, reported financial results for the first quarter 2024.